This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Dr. Christopher von Jako has served as President and Chief Executive Officer (CEO) since January 2020. He brings extensive leadership and experience in the global medical device market with over 25 years focusing on the development and commercialization of minimal invasive techniques to improve patient experience and outcomes. Most recently, Chris served as CEO of Dynatronics, a publicly-traded medical device company that designs, manufactures, and sells high-quality restorative products. Prior to Dynatronics, he served as President and CEO of NinePoint Medical, a privately-held medical device company that designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, and ENT. Additionally, Chris served as President and CEO of NeuroTherm, a privately-held, minimally invasive interventional pain management company. In 2014, he successfully executed the divesture of NeuroTherm with his team to St. Jude Medical. Earlier in his career, he held increasingly senior roles with other leading medical device companies, including Integra LifeSciences, Covidien, Medtronic, and Radionics.
Chris holds a Ph.D. in Biomedical Sciences from the University of Pécs, a M.S. degree in Radiological Sciences and Technology from the department of Nuclear Engineering at the Massachusetts Institute of Technology, and a double B.S. degree in Physics and Mathematics from Bates College. Additionally, he continues to serve as an independent director on the boards of NinePoint Medical, Inc. and nView medical, Inc.